In a case--control study, we examined the relation between fetal loss and occupational exposure to antineoplastic drugs in nurses in 17 Finnish hospitals. The pregnancies studied occurred in 1973 through 1980 and were identified using three national sources: the Central Register of Health Care Personnel, the Hospital Discharge Registry, and policlinic data. Each nurse with fetal loss was matched with three nurses who gave birth. Data on health and exposure were obtained by self-administered, mailed questionnaires; a response rate of 87 per cent was achieved after three mailings. A statistically significant association was observed between fetal loss and occupational exposure to antineoplastic drugs during the first trimester of pregnancy: odds ratio = 2.30 (95 per cent confidence interval, 1.20 to 4.39). Analyses suggested associations between fetal loss and cyclophosphamide, doxorubicin, and vincristine, although the independent effect of each individual drug could not be specifically identified, since many nurses reported handling more than one of these agents. The results of this study, combined with existing data on animals and human beings, suggest that caution be exercised in the handling of these valuable drugs.
FRANSMAN, W., PEELEN, S., HILHORST, S., ROELEVELD, N., Heederik, D., KROMHOUT, H.
(2007). A Pooled Analysis to Study Trends in Exposure to Antineoplastic Drugs Among Nurses. ANN OCCUP HYG
51: 231-239
[Abstract][Full Text]
Bussieres, J.-F., Theoret, Y., Prot-Labarthe, S., Larocque, D.
(2007). Program to monitor surface contamination by methotrexate in a hematology-oncology satellite pharmacy. Am J Health Syst Pharm
64: 531-535
[Abstract][Full Text]
Connor, T. H., McDiarmid, M. A.
(2006). Preventing Occupational Exposures to Antineoplastic Drugs in Health Care Settings. CA Cancer J Clin
56: 354-365
[Abstract][Full Text]
MEIJSTER, T., FRANSMAN, W., VELDHOF, R., KROMHOUT, H.
(2006). Exposure to Antineoplastic Drugs Outside the Hospital Environment. ANN OCCUP HYG
50: 657-664
[Abstract][Full Text]
Harrison, B. R., Peters, B. G., Bing, M. R.
(2006). Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.. Am J Health Syst Pharm
63: 1736-1744
[Abstract][Full Text]
(2006). ASHP Guidelines on Handling Hazardous Drugs. Am J Health Syst Pharm
63: 1172-1191
[Full Text]
Roberts, S., Khammo, N., McDonnell, G., Sewell, G. J
(2006). Studies on the decontamination of surfaces exposed to cytotoxic drugs in chemotherapy workstations. J Oncol Pharm Pract
12: 95-104
[Abstract]
Dranitsaris, G., Johnston, M., Poirier, S., Schueller, T., Milliken, D., Green, E., Zanke, B.
(2005). Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J Oncol Pharm Pract
11: 69-78
[Abstract]
FRANSMAN, W., VERMEULEN, R., KROMHOUT, H.
(2004). Occupational Dermal Exposure to Cyclophosphamide in Dutch Hospitals: A Pilot Study. ANN OCCUP HYG
48: 237-244
[Abstract][Full Text]
Favier, B., Gilles, L., Ardiet, C., Latour, J. F.
(2003). External contamination of vials containing cytotoxic agents supplied by pharmaceutical manufacturers. J Oncol Pharm Pract
9: 15-20
[Abstract]
Webster, P. J., Ng, K., Snitch, P., Jones, S. L., Amos, N., Hamett, P. R.
(1995). Does determination of tissue platinum levels by mass spectroscopy have potential for monitoring exposure of pharmacy personnel to platinum-based antineoplastic drugs? A pilot study. J Oncol Pharm Pract
1: 41-48
[Abstract]
Kuller, J. A., Laifer, S. A.
(1994). Preconceptional Counseling and Intervention. Arch Intern Med
154: 2273-2280
[Abstract]
Klebanoff, M. A., Shiono, P. H., Rhoads, G. G.
(1991). Spontaneous and Induced Abortion Among Resident Physicians. JAMA
265: 2821-2825
[Abstract]
Gallelli, J. F.
(1991). Issues and Risks Associated With Handling Antineoplastic Drugs. Journal of Pharmacy Practice
4: 72-76
Li, F. P., Gimbrere, K., Gelber, R. D., Sallan, S. E., Flamant, F., Green, D. M., Heyn, R. M., Meadows, A. T.
(1987). Outcome of Pregnancy in Survivors of Wilms' Tumor. JAMA
257: 216-219
[Abstract]